Inhibrx Biosciences Statistics
Total Valuation
INBX has a market cap or net worth of $1.40 billion. The enterprise value is $1.42 billion.
| Market Cap | 1.40B |
| Enterprise Value | 1.42B |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INBX has 14.67 million shares outstanding. The number of shares has increased by 0.49% in one year.
| Current Share Class | 14.67M |
| Shares Outstanding | 14.67M |
| Shares Change (YoY) | +0.49% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 15.26% |
| Owned by Institutions (%) | 61.50% |
| Float | 8.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,075.62 |
| Forward PS | 145.66 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,090.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.46
| Current Ratio | 6.46 |
| Quick Ratio | 6.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.45 |
Financial Efficiency
Return on equity (ROE) is -354.69% and return on invested capital (ROIC) is -42.63%.
| Return on Equity (ROE) | -354.69% |
| Return on Assets (ROA) | -36.06% |
| Return on Invested Capital (ROIC) | -42.63% |
| Return on Capital Employed (ROCE) | -78.15% |
| Weighted Average Cost of Capital (WACC) | 20.59% |
| Revenue Per Employee | $11,818 |
| Profits Per Employee | -$1.18M |
| Employee Count | 110 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 58.85 |
Taxes
In the past 12 months, INBX has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +545.73% in the last 52 weeks. The beta is 3.32, so INBX's price volatility has been higher than the market average.
| Beta (5Y) | 3.32 |
| 52-Week Price Change | +545.73% |
| 50-Day Moving Average | 105.83 |
| 200-Day Moving Average | 76.38 |
| Relative Strength Index (RSI) | 47.28 |
| Average Volume (20 Days) | 321,807 |
Short Selling Information
The latest short interest is 3.18 million, so 21.67% of the outstanding shares have been sold short.
| Short Interest | 3.18M |
| Short Previous Month | 2.93M |
| Short % of Shares Out | 21.67% |
| Short % of Float | 37.99% |
| Short Ratio (days to cover) | 6.19 |
Income Statement
In the last 12 months, INBX had revenue of $1.30 million and -$130.19 million in losses. Loss per share was -$8.39.
| Revenue | 1.30M |
| Gross Profit | -100.07M |
| Operating Income | -123.05M |
| Pretax Income | -130.18M |
| Net Income | -130.19M |
| EBITDA | -120.71M |
| EBIT | -123.05M |
| Loss Per Share | -$8.39 |
Balance Sheet
The company has $161.66 million in cash and $180.90 million in debt, with a net cash position of -$19.24 million or -$1.31 per share.
| Cash & Cash Equivalents | 161.66M |
| Total Debt | 180.90M |
| Net Cash | -19.24M |
| Net Cash Per Share | -$1.31 |
| Equity (Book Value) | -21.04M |
| Book Value Per Share | -1.44 |
| Working Capital | 144.83M |
Cash Flow
In the last 12 months, operating cash flow was -$131.93 million and capital expenditures -$10,000, giving a free cash flow of -$131.94 million.
| Operating Cash Flow | -131.93M |
| Capital Expenditures | -10,000 |
| Depreciation & Amortization | 2.35M |
| Net Borrowing | 74.99M |
| Free Cash Flow | -131.94M |
| FCF Per Share | -$8.99 |
Margins
| Gross Margin | n/a |
| Operating Margin | -9,465.46% |
| Pretax Margin | -10,014.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.49% |
| Shareholder Yield | -0.49% |
| Earnings Yield | -9.31% |
| FCF Yield | -9.44% |
Analyst Forecast
The average price target for INBX is $277.50, which is 191.16% higher than the current price. The consensus rating is "Buy".
| Price Target | $277.50 |
| Price Target Difference | 191.16% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 365.76% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
INBX has an Altman Z-Score of -1.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.48 |
| Piotroski F-Score | 3 |